PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Clayton, Dubilier & Rice appoints operating adviser

Clayton, Dubilier & Rice has appointed Liam FitzGerald, former chief executive officer of UDG Healthcare, as an operating adviser to CD&R funds. 

FitzGerald will work out of CD&R’s London office.
 
As CEO of UDG Healthcare from 2000 until 2016, FitzGerald expanded the business from a mainly Irish-based distribution services business into a multi-faceted and multi-national healthcare services group, operating across 20 countries. During that period, the company’s market capitalisation increased by more than 500 per cent and earnings grew at a compound annual rate of more than 20 per cent.
 
FitzGerald is credited with leading and integrating more than 30 acquisitions into the parent company.
 
“Liam is a recognised leader who has a demonstrated record of driving sustained enterprise growth, market share gains and value creation on a global scale,” says CD&R partner David Novak. “He brings valuable healthcare industry expertise, deep market insights and a broad network, particularly in Europe where we are enthusiastic about the investment opportunities presented by strong secular trends in the healthcare space.”
 
Prior to serving as CEO of UDG Healthcare, FitzGerald was the company’s director of healthcare supply chain from 1996 until 2000, where he was responsible for strategic planning and delivering revenue and EBIT targets for the group. As business development manager for the company’s drug distribution unit from 1993 until 1996, FitzGerald oversaw the doubling of the business unit’s market share of the outsourced pharmaceuticals distribution sector to 60 percent from 30 percent.
 
“This is a very exciting time to invest in healthcare, a sector where CD&R has an established record of success,” says FitzGerald. “I look forward to helping the team continue to make great healthcare investments, as well as build great businesses, in both Europe and the US.”

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured